InvestorsHub Logo
Followers 7
Posts 239
Boards Moderated 0
Alias Born 03/18/2021

Re: None

Saturday, 04/10/2021 11:53:02 PM

Saturday, April 10, 2021 11:53:02 PM

Post# of 8299
After Fridays news, $5 Target and BUY rating from H.C. WAINWRIGHT, TENAX THERAPEUTICS INC. (NASDAQ: TENX) Price Target: $5

This week Tenax announced the publication of positive data from its Phase 2 HELP study. The study evaluated the company’s levosimendan in patients with pulmonary hypertension and heart failure. Results of the placebo-controlled HELP trial were published in the American College of Cardiology Heart Failure.

“The fact that 84% of the patients enrolled in the initial lead-in phase had a significant hemodynamic response at rest and with exercise during cardiac catheterization provides confidence that levosimendan may be an important treatment for these patients who have a large unmet need.”
Dr. Stuart Rich, Chief Medical Officer at Tenax Therapeutics

With progress like this, Tenax has attracted several analysts. H.C. Wainwright issued a Buy rating on TENX along with a $5 price target. Based on Thursday’s closing price, H.C.’s TENX stock forecast sits roughly 180% higher than those levels.

https://quotes.freerealtime.com/quotes/TENX/News 04/09/21 09:48am
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News